Archives: 2020-06-05

PIER MARIA FORNASARI
2020-06-05

Emory doctors find link between hyperviscosity, clotting and inflammation in COVID-19 patients. Potential role for plasma exchange.

After noticing unusual blood clotting in many patients diagnosed with COVID-19, doctors at Emory University believe there may be a connection to the thickness of their blood, known as hyperviscosity, with inflammation and clotting. The correspondence, which links hyperviscosity and severity of illness, has been published in The Lancet’s online first section. “It has been a mystery

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2020-06-04

A published trial on Convalescent Plasma in Covid-19 doesn’t show conclusive results but severely ill patients recovered five days faster

Infusions of antibody-rich blood plasma from people who have recovered from the coronavirus, so-called convalescent plasma, failed to make a difference in a study of hospitalized patients in China, researchers reported on Wednesday in the Journal of the American Medical Association. In a randomized trial involving 103 COVID-19 patients, convalescent plasma made no difference in

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2020-06-02

First clinical trial of COVID-19 antibody therapy started. Why should be better than convalescent plasma ?

Eli Lilly has begun dosing COVID-19 patients in a phase 1 trial of its AbCellera-partnered antibody. The initiation of the trial, which happened ahead of schedule, marks the start of a new phase of the response to SARS-CoV-2 in which study subjects will receive drugs designed specifically for the virus. The first clinical trials of drugs to

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2020-06-02

Two meters apart from each other is far more effective than just one at reducing the risk of spreading SARS-CoV-2.

Two-meter distancing might halve infection risk compared to one meter, according to a new review analysis in The Lancet.  The researchers combed through 172 observational studies across 16 countries and then applied statistical analysis to pull out estimates of of risk of infection. The models they used on nine key studies found that transmission of viruses

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2020-06-02

APPA: New effective treatment for harmful effects of neutrophils in inflammatory diseases found at the Liverpool University

New research conducted by the University of Liverpool and AKL Research and Development Ltd (AKLRD), published in Inflammopharmacology, highlights the potential benefits of a new drug treatment on the human body’s immune response in inflammation. In a number of inflammatory conditions, such as osteoarthritis, rheumatoid arthritis and, more recently, COVID-19, major complications and extensive tissue damage can occur

Read More

No Comments InCovid-19